January 23, 2026: We're searching for new Blue Protocol codes for Season 2 and the release of Chaotic Realm: Rock Serpent Lair What are the latest Blue Protocol Star Resonance codes? To get a head ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...
Technical details and a public exploit have been published for a critical vulnerability affecting Fortinet's Security Information and Event Management (SIEM) solution that could be leveraged by a ...
Fortinet has released updates to fix a critical security flaw impacting FortiSIEM that could allow an unauthenticated attacker to achieve code execution on susceptible instances. The operating system ...
On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...
Anthropic’s agentic tool Claude Code has been an enormous hit with some software developers and hobbyists, and now the company is bringing that modality to more general office work with a new feature ...
Abstract: In recent years, large language models (LLMs) have made significant progress in code generation. However, as these models are increasingly adopted for software development, their associated ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...
Wegovy is now available as a daily oral pill with the same active ingredient as the injection. For some people, the pill may cause more intense side effects and slightly less weight loss than the ...
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of Cincinnati's best-funded ...
The Empaveli Injector. [Image courtesy of Enable Injections/Apellis Pharma] Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.